Woodline Partners LP Immunome Inc. Transaction History
Woodline Partners LP
- $10.5 Billion
- Q1 2024
A detailed history of Woodline Partners LP transactions in Immunome Inc. stock. As of the latest transaction made, Woodline Partners LP holds 1,318,056 shares of IMNM stock, worth $19.7 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
1,318,056
Previous 922,892
42.82%
Holding current value
$19.7 Million
Previous $9.87 Million
229.44%
% of portfolio
0.31%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding IMNM
# of Institutions
106Shares Held
32.1MCall Options Held
46.1KPut Options Held
32.5K-
Redmile Group, LLC San Francisco, CA4.89MShares$73 Million4.76% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$58 Million2.73% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.25MShares$33.6 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.02MShares$30.2 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.64MShares$24.5 Million0.1% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $181M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...